---

Bill Title: As enacted, adds nonopioid medicinal drugs or drug products, occupational therapy, and interventional procedures or treatments to the alternative treatments that must be disclosed and explained by a healthcare practitioner to a patient or the patient's legal representative as a prerequisite to obtaining informed consent to treatment with an opioid. - Amends TCA Section 63-1-164.

Spectrum: Bipartisan Bill

Status: (Passed) 2020-03-26 - Pub. Ch. 573 [SB1912 Detail]

Download: Tennessee-2019-SB1912-Chaptered.pdf

---